Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-17

Clinical Trial Update: Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MBX-102 for safety and effectiveness in adults with type 2 diabetes mellitus inadequately controlled on metformin has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MBX-102

Snippet

Sponsor: Gilead Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: TERMINATED